Angus Grant joins BeiGene; plus changes at Sarepta, RegenxBio, BioMarin, Novavax, Whitehead, Akcea and more

BeiGene Ltd. (NASDAQ:BGNE; HKEX:6160) hired Angus Grant as chief business executive, a new position at the cancer company. He was CEO of the Dementia Discovery Fund.

After eight years with Sarepta Therapeutics Inc. (NASDAQ:SRPT), EVP, CFO and CBO Sandy Mahatme will retire from the rare disease company, effective July 10. His responsibilities will be delegated to the executive team until the company finds a successor.

Donald Hayden

Read the full 659 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE